share_log

Nektar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(9.9%),TCG Crossover Fund II, L.P.(9.9%), etc.

Nektar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals

内克塔治疗 | SC 13G:超过5%持股股东披露文件
SEC announcement ·  03/15 16:27
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息